0 Items
My account
Phone: (011) 7541-421, 3409-301, 3409-335, 6547-293, 3409-310
E-mail: Standards sales: prodaja@iss.rs Education: iss-edukacija@iss.rs Information about standards: infocentar@iss.rs
Stevana Brakusa 2, 11030 Beograd
Main menu

ISO 22442-3:2007

Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents

Nov 27, 2007

General information

90.92     Oct 29, 2024

ISO

ISO/TC 194

International Standard

11.100.20  

English   French   Russian  

Buying

Published

Language in which you want to receive the document.

Scope

ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.

Life cycle

NOW

PUBLISHED
ISO 22442-3:2007
90.92 Standard to be revised
Oct 29, 2024

REVISED BY

PROJECT
ISO/AWI 22442-3

National adoptions

SRPS EN ISO 22442-3:2011  
ISS

Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (ISO 22442-3:2007)

60.60   Standard published

Z076 more